Infasurf

Infasurf is a lung surface acting agent, or "surfactant." It helps the lungs work properly. This medicine is similar to the natural fluid in the lungs that helps keep breathing effective.

Infasurf is used to treat or prevent respiratory distress syndrome (RDS) in a premature baby whose lungs have not fully developed.

Infasurf may also be used for other reasons not mentioned in this medication guide.

Your baby will receive this medication in a neonatal intensive care unit (NICU) or similar hospital setting.

Infasurf is given directly into the baby's lungs through a breathing tube that is also connected to a ventilator (a machine that moves air in and out of the lungs to help your baby breathe easier and get enough oxygen).

Your baby will remain under constant supervision during treatment with Infasurf.

To help with your baby's care while they are in the NICU, please follow all instructions given by your baby's caregivers closely.

Infasurf causes few side effects. There is a chance that the baby will have breathing difficulties during treatment with this medicine, and these issues may need additional treatment by health care professionals. Your baby will be closely monitored during treatment with this medicine.

This is not a complete list of side effects, and others may happen. Call your doctor for medical advice about side effects. You can report side effects to the FDA at 1-800-FDA-1088.

Infasurf is given directly into the baby's lungs through a breathing tube. Your baby will receive this medication in a neonatal intensive care unit (NICU) or similar hospital setting.

The breathing tube is connected to a ventilator (a machine that moves air in and out of the lungs to help your baby breathe easier and get enough oxygen).

Infasurf is given as soon as possible after the baby's birth, usually within 30 minutes.

Infasurf is usually given every 12 hours for up to 3 doses.

Your baby's breathing, blood pressure, oxygen levels, and other vital signs will be watched closely during treatment with Infasurf.

Since Infasurf is administered as needed by a healthcare professional, it is unlikely that your baby will miss a dose.

Since Infasurf is given in a controlled medical setting by a healthcare professional, an overdose is not likely to occur. However, an overdose of calfactant is not expected to cause life-threatening symptoms.

Follow your doctor's instructions regarding any restrictions on feeding, medications, or activity after your baby has been treated with Infasurf.

Your baby's caregivers will take care of and keep an eye on all medications your baby receives while in the NICU. A drug interaction between Infasurf and other medications is not expected to happen.

Do not give any medications to your baby that have not been prescribed by the baby's doctor. This includes vitamins, minerals, or herbal products.